Raymond James Financial Inc Takeda Pharmaceutical CO LTD Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Raymond James Financial Inc holds 82,182 shares of TAK stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,182
Previous 109,317
24.82%
Holding current value
$1.21 Million
Previous $1.45 Million
15.55%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TAK
# of Institutions
360Shares Held
67.4MCall Options Held
1.72MPut Options Held
186K-
Capital Research Global Investors Los Angeles, CA13.2MShares$194 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.7MShares$83.7 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$78.1 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.5MShares$51.4 Million0.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.43MShares$50.4 Million0.1% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.6B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...